Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

12,671 total articles

Radiopharm Theranostics Reports Business Update

Radiopharm Theranostics Reports Business Update

Radiopharm Theranostics provided a business update highlighting completion of enrollment in a Phase 2b trial of RAD 101 with promising 90% concordance to MRI. Positive early Phase 0/1 data for RAD 202 was presented with a recommendation to escalate dosing. Two first-in-human trials were initiated for RV-01 and RAD 402 targeting multiple cancers. Fi…

Genenta signs Definitive Agreements with Sophia High Tech

Genenta signs Definitive Agreements with Sophia High Tech

Genenta Science, listed on Nasdaq under the ticker GNTA and evolving into Saentra Forge, has signed definitive agreements to acquire a majority 51% stake in Italian aerospace and defense manufacturer Sòphia High Tech through two €6 million tranches. Sòphia High Tech specializes in critical mechanical components for space and defense programs and sh…

Roper Technologies announces first quarter financial results

Roper Technologies announces first quarter financial results

Roper Technologies announced robust first quarter 2026 financial results with total revenue increasing 11% to $2.10 billion driven by 6% organic growth and 5% from acquisitions. GAAP net earnings surged 54%, and adjusted earnings per diluted share rose 8% to $5.16, supported by strong operating cash flow and strategic share repurchases totaling $1.…

Bread Financial Provides Performance Update for March 2026

Bread Financial Provides Performance Update for March 2026

Bread Financial Holdings, Inc. released its March 2026 performance update, reporting steady credit card loan growth and improved delinquency rates compared to the prior year. The company continues to provide technology-driven financial services across various U.S. consumer sectors and highlighted its ongoing risk factors and forward-looking stateme…

Bread Financial Reports First Quarter 2026 Results

Bread Financial Reports First Quarter 2026 Results

Bread Financial Holdings, a tech-forward financial services company, announced its first quarter 2026 financial results and plans an earnings conference call to discuss the details. The company offers payment, lending, and saving solutions, including co-brand and private label credit cards, and marks 30 years of operation in 2026.

Bread Financial Declares Dividends on Preferred and Common Stock

Bread Financial Declares Dividends on Preferred and Common Stock

Bread Financial Holdings, Inc. declared quarterly dividends for its 8.625% Non-Cumulative Perpetual Preferred Stock (Series A) and common stock. Preferred stockholders will receive $21.56 per share, and common stockholders will receive $0.23 per share, both payable on June 15, 2026 to shareholders of record as of May 29, 2026. Bread Financial is a …

Acme United Reports First Quarter 2026 Financial Results

Acme United Reports First Quarter 2026 Financial Results

Acme United Corporation reported a 14% increase in net sales to $52.3 million for Q1 2026, driven by acquisitions and organic growth. However, net income declined 40% to $1.0 million due to higher tariffs, increased operating expenses, and investments in quality assurance. The recent acquisition of My Medic contributed to sales growth but had minim…

Texas Capital Bancshares, Inc. Announces First Quarter 2026 Results

Texas Capital Bancshares, Inc. Announces First Quarter 2026 Results

Texas Capital Bancshares, Inc. announced its Q1 2026 results showing a 63% year-over-year increase in net income available to common stockholders to $69.5 million. The company reported growth in book value per share and strong capital ratios. Significantly, they initiated a quarterly common stock cash dividend of $0.20 per share. Key drivers includ…

Gentherm Reports 2026 First Quarter Results

Gentherm Reports 2026 First Quarter Results

Gentherm reported record first quarter 2026 revenue of $394 million, up 7.2% excluding foreign exchange impact, driven by strong automotive segment growth. The company improved gross margin and net income compared to prior year, and announced a strategic combination with Modine Performance Technologies, expected to close in 2026, to create a leader…

FirstCash Reports Record First Quarter Operating Results; Revenues Increase 26%, Driving 30% Growth in Earnings per Share; Pawn Receivable Growth Accelerates; Revenue Guidance Increased for 2026

FirstCash Reports Record First Quarter Operating Results; Revenues Increase 26%, Driving 30% Growth in Earnings per Share; Pawn Receivable Growth Accelerates; Revenue Guidance Increased for 2026

FirstCash Holdings, Inc. reported record operating results for Q1 2026, with revenues increasing 26% to over $1 billion, driving a 30% increase in diluted earnings per share. Growth was strong across its pawn segments in the U.S., Latin America, and the recently acquired U.K. operations, with pawn receivables significantly accelerating. The company…

Auddia Expands AI Infrastructure Moat with 14th Patent Supporting Distributed Edge Data Center Deployments

Auddia Expands AI Infrastructure Moat with 14th Patent Supporting Distributed Edge Data Center Deployments

Auddia Inc. announced that the U.S. Patent and Trademark Office has allowed its 14th patent for the LT350 canopy-based AI deployment platform, which converts parking lot airspace into distributed AI inference data centers. The expanded IP portfolio, now encompassing 16 issued and pending patents, covers key innovations in canopy architecture, modul…

Greenwich LifeSciences Announces Acceptance of Abstract at ASCO 2026

Greenwich LifeSciences Announces Acceptance of Abstract at ASCO 2026

Greenwich LifeSciences, a clinical-stage biopharmaceutical company (Nasdaq: GLSI), announced that an abstract detailing preliminary data from its Phase III FLAMINGO-01 trial of GLSI-100, an immunotherapy to prevent breast cancer recurrence, has been accepted for presentation at the 2026 ASCO Annual Meeting. The open-label arm data show an approxima…